Some GPCRs have low median expression (<1 TPM) in the tumor population in general (e.g., taste receptors TAS2R14 and TAS2R20 in ESCA) but may be expressed in subsets of these populations, wherein they may contribute to differences in survival. Here, TAS2R14 is linked to neoplasm.